Thyroid vascularization by color Doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease

Thyroid

Volumn 7, Issue 6, 1997, Pages 823-828

  Baldini, Marina ^a   Castagnone, Daniela ^b   Rivolta, Roberto ^b   Meroni, Laura ^a   Pappalettera, Marco ^b   Cantalamessa, Luigi ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; RECEPTOR ANTIBODY; THIAMAZOLE; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; BLOOD FLOW; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; DISEASE ACTIVITY; ECHOGRAPHY; FEMALE; FREE THYROXINE INDEX; GRAVES DISEASE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; ORGAN BLOOD FLOW; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; THYROID GLAND; VASCULARIZATION;

EID: 0031435305     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.823     Document Type: Article

References (17)

1. Marcocci C, Vitti P, Cetani F, Catalano F, Concetti R, Pinchera A 1991 Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab 72:209-213.
2. Vitti P, Rago T, Mazzeo S, Brogioni S, Lampis M, De Liperi A, Bartolozzi C, Pinchera A, Martini E 1995 Thyroid blood flow evaluation by color-flow Doppler ultrasonography distinguishes Graves' disease from Hashimoto's thyroiditis. J Endocrinol Invest 18:857-861.
3. Muller HW, Schroder S, Schneider C, Seiffert G 1986 Sonographic tissue characterisation in thyroid gland diagnosis. Klin Wochenschr 63:706-710.
4. Vitti P, Rago T, Mancusi F, Pallini S, Tonacchera M, Santini F, Chiovato L, Marcocci C, Pinchera A 1992 Thyroid hypoechogenic pattern at ultrasonography as a tool for predicting recurrence of hyperthyroidism after medical treatment in patients with Graves' disease. Acta Endocrinol (Copenh) 126:128-131.
5. Hodgson KJ, Lazarus JH, Wheeler MH, Woodcock JP, Owen GM, McGregor AM, Hall R 1988 Duplex scan-derived thyroid blood flow in euthyroid and hyperthyroid patients. World J Surg 12:470-475.
6. Ralls PW, Mayekawa DS, Lee KP, Colletti PM, Radin DR, Boswell WD, Halls JM 1988 Color-flow doppler sonography in Graves' disease: "Thyroid inferno." AJR 150:781-784.
7. Brown MC, Spenser R 1978 Thyroid gland volume estimated by use of ultrasound in addition to scintigraphy. Acta Radiol (Oncol) 17:37-41.
8. Castagnone D, Rivolta R, Rescalli S, Baldini IM, Tozzi R, Cantalamessa L 1996 Color doppler sonography in Graves' disease: Value in assessing activity of disease and predicting outcome. AJR 166:203-207.
9. Fobbe F, Finke R, Reichenstein E, Schleusener H, Wolf KJ 1989 Appearance of thyroid diseases under colour-coded duplex sonography. Eur J Radiol 9:29-31.
10. Marigold JH, Morgan AK, Earles DJ, Young AE, Croft DN 1977 Lugol's iodine: Its effect on thyroid blood flow in patients with thyrotoxicosis. Acta Endocrinol (Copenh) 86:317-320.
11. Fukuchi M, Kido A, Hyodo K, Tachibana K, Onoue K, Morita T, Nagai K 1979 Uptake of thallium-201 in enlarged thyroid glands: Concise communication. J Nucl Med 20:827-828.
12. Cassidy CE 1965 Use of a thyroid suppression test as a guide to prognosis of hyperthyroidism treated with antithyroid drugs. J Clin Endocrinol 25:155-156.
13. Dahlberg PA, Karlsson FA, Jansson R, Wide L 1985 Thyrotropin-releasing hormone testing during antithyroid drug treatment of Graves' disease as an indicator of remission. J Clin Endocrinol Metab 61:1100-1104.
14. Schleusener H, Schwander J, Fischer C, Holle R, Badenhoop K, Hensen J, Finke R, Bogner U, Mayr WR, Schernthaner G, Schatz H, Pickardt CR, Kotulla P 1989 Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol (Copenh) 120:689-701.
15. Hershman JM, Givens JR, Cassidy CE, Astwood EB 1966 Long-term outcome of hyperthyroidism treated with antithyroid drugs. J Clin Endocrinol Metab 26:803-808.
16. Garcìa-Mayor RVG, Pàramo C, Luna Cano R, Ferez Mendez LF, Galofrè JC, Andrade A 1992 Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission. J Endocrinol Invest 15:815-820.
17. Baldini M, Pappalettera M, Lecchi L, Orsatti A, Tozzi R, Scalamogna M, Cantalamessa L 1995 HLA antigens in Graves' disease: correlation with persisting course of disease. Am J Med Sci 309:43-48.